Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Functional rare variants influence the clinical response to anti-TNF therapy in Crohn's disease.
Chaparro M, Aterido A, Guerra I, Iborra M, Cabriada JL, Bujanda L, Taxonera C, García-Sánchez V, Marín-Jiménez I, Barreiro-de Acosta M, Vera I, Martín-Arranz MD, Hernández-Breijo B, Mesonero F, Sempere L, Gomollón F, Hinojosa J, Bermejo F, Beltrán B, Rodríguez-Pescador A, Banales JM, Olivares D, Aguilar-Melero P, Menchén L, Ferreiro-Iglesias R, Blazquez Gómez I, Benitez García B, Guijarro LG, Marin AC, Bernardo D, Marsal S, Julia A, Gisbert JP. Chaparro M, et al. Therap Adv Gastroenterol. 2019 Sep 25;12:1756284819867848. doi: 10.1177/1756284819867848. eCollection 2019. Therap Adv Gastroenterol. 2019. PMID: 31598133 Free PMC article.
Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis.
Bermejo F, Lopez-Sanroman A, Taxonera C, Gisbert JP, Pérez-Calle JL, Vera I, Menchén L, Martín-Arranz MD, Opio V, Carneros JA, Van-Domselaar M, Mendoza JL, Luna M, López P, Calvo M, Algaba A. Bermejo F, et al. Aliment Pharmacol Ther. 2008 Sep 1;28(5):623-8. doi: 10.1111/j.1365-2036.2008.03746.x. Epub 2008 May 30. Aliment Pharmacol Ther. 2008. PMID: 18513380 Free article.
Smoking does influence disease behaviour and impacts the need for therapy in Crohn's disease in the biologic era.
Nunes T, Etchevers MJ, Domènech E, García-Sánchez V, Ber Y, Peñalva M, Merino O, Nos P, Garcia-Planella E, Casbas AG, Esteve M, Taxonera Samsó C, Montoro Huguet M, Gisbert JP, Martín Arranz MD, García-Sepulcre MF, Barreiro-de Acosta M, Beltrán B, Alcaide Suárez N, Saro Gismera C, Cabriada JL, Cañas-Ventura A, Gomollón F, Panés J; Tobacco-Eneida Study Group of GETECCU. Nunes T, et al. Aliment Pharmacol Ther. 2013 Oct;38(7):752-60. doi: 10.1111/apt.12440. Epub 2013 Aug 26. Aliment Pharmacol Ther. 2013. PMID: 23980933 Free article.
Role of TNFRSF1B polymorphisms in the response of Crohn's disease patients to infliximab.
Medrano LM, Taxonera C, Márquez A, Barreiro-de Acosta M, Gómez-García M, González-Artacho C, Pérez-Calle JL, Bermejo F, Lopez-Sanromán A, Martín Arranz MD, Gisbert JP, Mendoza JL, Martín J, Urcelay E, Núñez C. Medrano LM, et al. Hum Immunol. 2014 Jan;75(1):71-5. doi: 10.1016/j.humimm.2013.09.017. Epub 2013 Oct 10. Hum Immunol. 2014. PMID: 24121042
Effectiveness of adalimumab in perianal fistulas in crohn's disease patients naive to anti-TNF therapy.
Castaño-Milla C, Chaparro M, Saro C, Barreiro-de Acosta M, García-Albert AM, Bujanda L, Martín-Arranz MD, Carpio D, Muñoz F, Manceñido N, García-Planella E, Piqueras M, Calvet X, Cabriada JL, Botella B, Bermejo F, Gisbert JP. Castaño-Milla C, et al. J Clin Gastroenterol. 2015 Jan;49(1):34-40. doi: 10.1097/MCG.0000000000000169. J Clin Gastroenterol. 2015. PMID: 25485513
Incidence, management, and course of cancer in patients with inflammatory bowel disease.
Algaba A, Guerra I, Marín-Jiménez I, Quintanilla E, López-Serrano P, García-Sánchez MC, Casis B, Taxonera C, Moral I, Chaparro M, Martín-Rodríguez D, Martín-Arranz MD, Manceñido N, Menchén L, López-Sanromán A, Castaño Á, Bermejo F. Algaba A, et al. J Crohns Colitis. 2015 Apr;9(4):326-33. doi: 10.1093/ecco-jcc/jjv032. Epub 2015 Feb 16. J Crohns Colitis. 2015. PMID: 25687203
Infliximab Dose Escalation as an Effective Strategy for Managing Secondary Loss of Response in Ulcerative Colitis.
Taxonera C, Barreiro-de Acosta M, Calvo M, Saro C, Bastida G, Martín-Arranz MD, Gisbert JP, García-Sánchez V, Marín-Jiménez I, Bermejo F, Chaparro M, Ponferrada Á, Martínez-Montiel MP, Pajares R, de Gracia C, Olivares D, Alba C, Mendoza JL, Fernández-Blanco I. Taxonera C, et al. Dig Dis Sci. 2015 Oct;60(10):3075-84. doi: 10.1007/s10620-015-3735-4. Epub 2015 Jun 5. Dig Dis Sci. 2015. PMID: 26044830
Thiopurine Therapy Reduces the Incidence of Colorectal Neoplasia in Patients with Ulcerative Colitis. Data from the ENEIDA Registry.
Gordillo J, Cabré E, Garcia-Planella E, Ricart E, Ber-Nieto Y, Márquez L, Rodríguez-Moranta F, Ponferrada Á, Vera I, Gisbert JP, Barrio J, Esteve M, Merino O, Muñoz F, Domènech E; ENEIDA Project of the Spanish Working Group in Crohn’s Disease and Ulcerative Colitis (GETECCU). Gordillo J, et al. J Crohns Colitis. 2015 Dec;9(12):1063-70. doi: 10.1093/ecco-jcc/jjv145. Epub 2015 Sep 7. J Crohns Colitis. 2015. PMID: 26351379
115 results